JOURNAL OF IMMUNOTHERAPY
Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.
Journal Title
JOURNAL OF IMMUNOTHERAPY
J IMMUNOTHER
ISSN / eISSN
1524-9557 / 1537-4513
Aims and Scope
Journal of Immunotherapy features rapid publication of articles on immunomodulators, lymphokines, antibodies, cells, and cell products in cancer biology and therapy. Laboratory and preclinical studies, as well as investigative clinical reports, are presented. The journal emphasizes basic mechanisms and methods for the rapid transfer of technology from the laboratory to the clinic. JIT contains full-length articles, review articles, and short communications.
Subject Area
IMMUNOLOGY
MEDICINE, RESEARCH & EXPERIMENTAL
ONCOLOGY
CiteScore
7.50
View Trend
CiteScore Ranking
Category | Quartile | Rank |
---|---|---|
Pharmacology, Toxicology and Pharmaceutics - Pharmacology | Q1 | #75/301 |
Pharmacology, Toxicology and Pharmaceutics - Immunology and Allergy | Q2 | #70/211 |
Pharmacology, Toxicology and Pharmaceutics - Immunology | Q2 | #79/217 |
Pharmacology, Toxicology and Pharmaceutics - Cancer Research | Q2 | #80/214 |
Web of Science Core Collection
Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
---|---|
Indexed | - |
Category (Journal Citation Reports 2023) | Quartile |
---|---|
IMMUNOLOGY - SCIE | Q3 |
MEDICINE, RESEARCH & EXPERIMENTAL - SCIE | Q3 |
ONCOLOGY - SCIE | Q2 |
H-index
89
Country/Area of Publication
UNITED STATES
Publisher
Lippincott Williams and Wilkins Ltd.
Publication Frequency
Monthly
Year Publication Started
1997
Annual Article Volume
51
Open Access
NO
Contact
LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More